DelveInsight Business Research Press Releases - EIN Presswire

Published on February 18, 2025 - 20:31 GMT

Gastric Neuroendocrine Tumors Market Expected to Experience Major Growth by 2032, According to DelveInsight

DelveInsight’s Gastric Neuroendocrine Tumors Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18, 2025 /⁨EINPresswire.com⁩/ -- The Gastric Neuroendocrine Tumors …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 18, 2025 - 20:31 GMT

Heparin Induced Thrombocytopenia Market Set to Grow Substantially Through 2034, DelveInsight Projects

DelveInsight’s Heparin Induced Thrombocytopenia Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18, 2025 /⁨EINPresswire.com⁩/ -- The Heparin-induced Thrombocytopenia …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 18, 2025 - 20:30 GMT

Glaucoma Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports

DelveInsight’s Glaucoma Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Glaucoma Market Insights, Epidemiology, and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 18, 2025 - 20:29 GMT

Gastroesophageal Reflux Disease Market Predicted to See Upsurge Through 2034, Highlights DelveInsight

DelveInsight’s Gastroesophageal Reflux Disease Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 18, 2025 /⁨EINPresswire.com⁩/ -- The Gastroesophageal Reflux Disease …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 20:43 GMT

SSc-ILD Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes

DelveInsight’s SSc-ILD Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Systemic Sclerosis-associated Interstitial …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 20:43 GMT

Idiopathic Pulmonary Fibrosis Market to Reach New Heights in Growth by 2034, DelveInsight Predicts

DelveInsight’s Idiopathic Pulmonary Fibrosis Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Idiopathic Pulmonary …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 20:43 GMT

Exocrine Pancreatic Insufficiency Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports

DelveInsight’s Exocrine Pancreatic Insufficiency Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Exocrine …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 20:42 GMT

Chronic Venous Insufficiency Market Set to Grow Substantially Through 2034, DelveInsight Projects

DelveInsight’s Chronic Venous Insufficiency Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “Chronic Venous …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 20:02 GMT

Progressive Familial Intrahepatic Cholestasis Market Expected to Experience Major Growth by 2034, States DelveInsight

DelveInsight’s Progressive Familial Intrahepatic Cholestasis Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s “ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 17:04 GMT

Alzheimer's Disease Clinical Trial Pipeline | 110+ Companies Pioneering Breakthroughs in Treatment | DelveInsight

Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth potential of the Alzheimer's disease treatment landscape. LAS VEGAS , NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 16:52 GMT

Multiple Sclerosis Clinical Trial Pipeline | 75+ Companies Driving Innovation in Treatment Advancement | DelveInsight

Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth potential of the Multiple Sclerosis treatment landscape. LAS VEGAS , NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s ' …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 16:51 GMT

Fabry Disease Clinical Trial Pipeline, 18+ Companies Leading the Way in Advancing Treatment | DelveInsight

Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth potential of the Fabry Disease treatment landscape. LAS VEGAS , NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s 'Fabry …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 16:50 GMT

Primary Biliary Cholangitis Clinical Trial Pipeline | 20+ Companies Pioneering the Future of Treatment

Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeline to unlock future growth potential. LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s 'Primary Biliary Cholangitis Pipeline …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 16:49 GMT

Dry Eye Disease Clinical Trial Pipeline | 45+ Companies Pioneering the Future of Treatment

Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth potential of the Dry Eye Disease treatment landscape. LAS VEGAS , NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s 'Dry …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 12:26 GMT

Pulmonary Arterial Hypertension Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA

Pulmonary Arterial Hypertension Pipeline LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “Pulmonary Arterial Hypertension Pipeline Insight” report provides comprehensive insights about 55+ companies and 55+ pipeline …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 12:08 GMT

Bladder Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

Bladder Cancer Pipeline LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “Bladder Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Bladder Cancer pipeline …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 11:55 GMT

IgG4-Related Disease Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, Companies

IgG4-Related Disease Pipeline LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “IgG4-Related Disease Pipeline Insight” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in IgG4-Related …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 11:13 GMT

Hyperuricemia Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

Hyperuricemia Pipeline LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “Hyperuricemia Pipeline Insight” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Hyperuricemia pipeline …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 10:35 GMT

Hereditary ATTR (hATTR) Amyloidosis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA

Hereditary ATTR (hATTR) Amyloidosis Pipeline LAS VEGAS, NV, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- DelveInsight’s, “Hereditary Transthyretin Amyloidosis Pipeline Insight” report provides comprehensive insights about 8+ companies and 8+ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 12, 2025 - 21:03 GMT

Diffuse Intrinsic Pontine Glioma Market Set to Grow Substantially Through 2032, DelveInsight Projects

LAS VEGAS, NV, UNITED STATES, February 12, 2025 /⁨EINPresswire.com⁩/ -- The Diffuse Intrinsic Pontine Glioma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various …

Distribution channels: Healthcare & Pharmaceuticals Industry ...